Finance Start-Up News: Breaking Finance Start-Up News, Comments and Articles. - Page: 4

Aggravating Aggregators

Compound aggregation is a well-known problem in biochemical assays (although if you go back a few years, that certainly wasn't the case). Some small molecules will start to bunch up under some assay conditions, and instead of your target protein gett...

Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013

BEIJING, June 17, 2013 /PRNewswire-FirstCall/ -- Yongye International, Inc. (NASDAQ:  YONG) ("Yongye" or the "Company"), a leading developer, manufacturer, and distributor of crop nutrient products in the People's Republic of China ("PRC"), announced today that its common stock will resume trading on the NASDAQ Stock Market on Monday, June 17, 2013 at 7:15 a.m. Eastern Time. As previous...

MedeAnalytics Introduces New Financial Strategy Analytics Solution for Hospitals and Health Systems at HFMA 2013 Annual National Institute

ORLANDO, Fla., June 17, 2013 /PRNewswire/ -- Today MedeAnalytics, a leading provider of healthcare performance management solutions, introduced its new Financial Strategy Analytics solution, a powerful tool that enables hospitals and health systems to proactively manage finances, hone strategic planning, and optimize managed care performance metrics in the context of today's rapidly cha...

Cytokinetics Set to Join Russell Global Index

South San Francisco, CA June 17, 2013 - Cytokinetics Incorporated (NASDAQ:CYTK) announced today that it is set to join the Russell Global Index when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 28, 2013, according to a preliminary list of additions posted June 14, 2013 on www.russell.com/indexes. Membership in the Russell Global Index, wh...

Complimentary Interactive Webinar, "Introduction to Scrum-Agile: 'What's in it for me?'” on Wed, Jun 26, 2013 12:00 PM – 1:00 PM US Pacific Time

In this complimentary 1-hour interactive webinar, "Introduction to Scrum-Agile: 'What's in it for me?'”, the participants will get an overview of the fundamental principles and mechanics of Scrum, and thereby an understanding of the benefits of adopting Scrum Principles and Values in an organization. Chicago (PRWEB) June 17, 2013 In this no-cost 1-hour interactive webinar, &quo...

Industry Veteran, John Maroney, to Join ForSight VISION5 as President and CEO

MENLO PARK, Calif., June 17, 2013 /PRNewswire/ -- ForSight VISION5 is pleased to announce that John F. Maroney will join the company as President, CEO and Director of VISION5, and that the company has recently closed its Series B-1 round of funding. ForSight VISION5 is the fifth company created by Menlo Park ophthalmic incubator ForSight Labs. VISION5 is a clinical development stage company f...

Intercept Pharmaceuticals Announces Proposed Public Offering of Common Stock

NEW YORK, June 17, 2013 /PRNewswire/ -- Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), a clinical stage biopharmaceutical company focused on the development and commercialization of novel bile acid therapeutics to treat chronic liver diseases, today announced that it has commenced an underwritten public offering of 1,730,000 shares of its common stock.  All of the shares in the off...

Arizona Startup Bust’DD Looking to Start a BRAvolution

Tempe, AZ (PRWEB) June 17, 2013 Bust’DD (pronounced ‘busted’), a new company that will provide bras that are both stylish and well-fitting to women with large busts, will soon launch their crowdfunding campaign on Indiegogo. The com...

Cytokinetics, Inc.: Cytokinetics Set to Join Russell Global Index

South San Francisco, CA June 17, 2013 - Cytokinetics Incorporated (NASDAQ:CYTK) announced today that it is set to join the Russell Global Index when Russell Investments reconstitutes its comprehen...

Eli Lilly & Co Halts Alzheimer's Drug Trial

Lee Rannals for redOrbit.com - Your Universe Online Eli Lilly & Co has ended a clinical trial for an Alzheimer's disease drug during the middle of the study after patients showed abnormal liver biochemical tests. The company announced last week that it would be putting a halt to its LY2886721 drug trial. LY2886721, the code-name for the drug, was designed to inhibit beta secretase, which con...

Cell Therapeutics to Join Russell 3000® and Russell Global Indexes

SEATTLE, June 17, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. ("CTI") (NASDAQ: CTIC and MTA: CTIC) announced today that it is set to join the broad-market Russell 3000® and Russell Global Indexes when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes on June 28, 2013, according to a preliminary list of additions posted on June...

Novel IP Policy Attracts Medical Device Research Funding At University Of Minnesota

The University of Minnesota’s Medical Devices Center, which just moved to a new 8,000 square-foot facility on the Minneapolis campus, is attracting great interest and investment from device makers. The director credits the university’s intellectu...

PT003: Phase III start

OMS721: Phase I start

Agenmestencel-T: Phase I/II start

LP tracks

Ebb & Flow LP tracks Janine Guillot stepped down as chief operating investment officer at the California Public Employees' Retirement System (CalPERS), effective May 24. Carol Moody was named interim COIO by CalPERS…

Funding QB3

Ebb & Flow Funding QB3 The California Institute for Quantitative Biosciences (QB3) and venture affiliate Mission Bay Capital hope to become self-sustaining, but they aren't there yet. Mission Bay aims to raise over…

Nuvo Research(R) and Paladin Labs Announce Amendment to May 2012 Loan Arrangement

MONTREAL, QUEBEC and MISSISSAUGA, ONTARIO -- (Marketwired) -- 06/17/13 -- Paladin Labs Inc. (TSX: PLB), a leading specialty pharmaceutical company and Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10, today announced that they have amen...

VistaGen Therapeutics Presents CardioSafe 3D(TM) and LiverSafe 3D(TM) Developments at International Society of Stem Cell Research's 11th Annual Meeting

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/17/13 -- VistaGen Therapeutics, Inc. (OTCQB: VSTA), a biotechnology company applying stem cell technology for drug rescue, predictive toxicology and drug metabolism assays, presented key developments involving its CardioSafe 3D™ and LiverSafe 3D™ bioassay systems in poster presentations at the 11th Annual Meeting of the International Society of Ste...

Myriant Achieves Major Milestone: Successful Start-Up

QUINCY, Mass., June 17, 2013 (GLOBE NEWSWIRE) -- Myriant Corporation, a global renewable chemicals company, announced today the successful start-up at its flagship bio-succinic acid plant located in Lake Providence, Louisiana. Myriant has produced on-spec commercial product at the plant and the Company anticipates that customer shipments will commence soon. Myriant's bio-succinic acid plant is th...

Elan Shareholders Do Not Approve Theravance/Elan Royalty Participation Transaction

SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 06/17/13 -- Theravance, Inc. (NASDAQ: THRX) ("Theravance") today announced that shareholders of Elan Corporation, plc ("Elan") did not approve the Theravance/Elan royalty participation transaction proposal at Elan's Extraordinary General Meeting held in Dublin, Ireland. "While we are disappointed that Elan's shareholders did not approve this transactio...

ImmunoGenes, Corvinus Venture Capital Fund Manager deal

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Crestwood Midstream Partners LP of Class Action Lawsuit and the Deadline of August 16, 2013 to Seek a Lead Plaintiff Position -- CMLP

NEW YORK, June 17, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a class action lawsuit was filed in the United States District Court for the Southern District of Texas on behalf of all holders of Crestwood Midstream Partners LP ("Crestwood" ) (NYSE:CMLP) stock on May 6, 2013, in connection with the proposed sale of Crestwood to Inergy, L.P. For more information, click here: http...

New Board Members Join Kerecis

REYKJAVIK, ICELAND and ISAFJORDUR, ICELAND -- (Marketwired) -- 06/17/13 -- Kerecis Limited, the emerging tissue-regeneration company, today announced that Andri Sveinsson and Kristjan Johannesson have been appointed to the company's board of directors. Sveinsson, a partner at Novator Partners LLP in London, has extensive experience in banking and corporate finance. He has held board positions in...

Making a case for transparent corporate accounting information

(University of California - Berkeley Haas School of Business) A new study by accounting professor Yaniv Konchitchki finds greater transparency in firms' earnings has a positive effect on the bottom line. "Cost of Capital and Earnings Transparency," (...